Scilex Holding Co PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- Scilex Holding Co pe ratio for the quarter ending 2026-06-30 was -0.14, a change of 0.36 year-over-year.
- Scilex Holding Co pe ratio for the quarter ending 2026-03-31 was -0.12, a change of 17.6 year-over-year.
- Scilex Holding Co pe ratio for the quarter ending 2025-12-31 was -0.23, a change of 0.44 year-over-year.
- Scilex Holding Co pe ratio for the quarter ending 2025-09-30 was -0.41, a change of 43.65 year-over-year.
- Scilex Holding Co pe ratio for fiscal 2026 was -0.14.
- Scilex Holding Co pe ratio for fiscal 2025 was -0.23, a change of 0.44 from fiscal 2024.
- Scilex Holding Co pe ratio for fiscal 2024 was -0.67, a change of 38.22 from fiscal 2023.
- Scilex Holding Co pe ratio for fiscal 2023 was -38.89, a change of 487.17 from fiscal 2022.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |